Giving Thanks Can Ease Pandemic Stress, SLU Expert Says

Saint Louis University Medical Center

Newswise — This time of year is usually a time of joy and celebration with family and friends. Yet, as COVID-19 cases surge across the country, Thanksgiving in 2020 will look different than it has in other years. A global pandemic, like COVID-19, can have a profound impact on a person’s psyche. 

“The pandemic is a real threat, more so in the early stages when we did not know enough about the virus, except that it’s spreading like wildfire, and people are dying,” said Suma Chand, Ph.D., associate professor in the department of psychiatry and behavioral neuroscience at Saint Louis University.

The lack of control and uncertainty can make a person feel more anxious and depressed than usual, Chand said. 

Chand says human beings are programmed to have what is known as negativity bias where we tend to pay more attention to the negative and threatening. Being vigilant for threats and negatives is a useful tool to keep us safe. Events such as the pandemic can throw negativity bias into overdrive resulting in hypervigilance. The excessive focus on threats and negatives trigger stress, anxiety, and depression.

Chand, a SLUCare clinical psychologist who specializes in cognitive behavior therapy (CBT), says cognitive restructuring techniques can be used to alter maladaptive thoughts by changing how you perceive events or circumstances. Chand says that the practice of gratitude, which is part of the Thanksgiving tradition, is a useful tool that helps change one’s mindset and improve one’s mood for the better. 

“In fact, studies have reported that practicing gratitude lowers the risk of depression, anxiety, substance abuse, and eating disorders,” Chand said. “Instead of focusing on the negativity of the pandemic, perhaps we all need to take time to be grateful and focus on the silver linings to help us sustain a positive attitude — to energize, to heal, and to bring hope.”

As Thanksgiving approaches, Chand offers several ideas to add to a pandemic gratitude list:

  • The rapid advances made in the medical field to eradicate the virus and treat the infection. 
  • The opportunity to spend more time outdoors in nature and explore new hobbies.
  • Greater appreciation for people in your life.
  • Thankfulness for those working on the frontlines like healthcare workers, grocery store clerks, and teachers. 

About Saint Louis University School of Medicine

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national, and international level. Research at the school seeks new cures and treatments in five key areas: cancer, liver disease, heart/lung disease, aging and brain disease, and infectious diseases.

About SLUCare Physician Group

SLUCare Physician Group is the academic medical practice of Saint Louis University, with more than 500 health care providers and 1,200 staff members in hospitals and medical offices throughout the St. Louis region. SLUCare physicians are among the most highly trained in their fields – more than 50 specialties in all – and are national and international experts, renowned for research and innovations in medicine. For more information, visit us at

Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573